bf/NASDAQ:RDUS_icon.jpeg

COM:RADIUSPHARM

Radius Health

  • Stock

Last Close

19.82

08/11 21:00

Market Cap

406.74M

Beta: -

Volume Today

191.13K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Aug '20
Dec '20
Aug '21
Dec '21
Aug '22
average inventory
2.18M
-
5.29M
142.24%
5.77M
9.05%
81.30M
1,309.80%
7.25M
91.08%
206.85M
2,753.67%
10.27M
95.03%
285.81M
2,681.99%
average payables
425K
-
1.30M
204.94%
4.26M
228.70%
6.18M
45.02%
5.02M
18.72%
4.07M
18.94%
5.13M
25.98%
56.35M
998.93%
7.98M
85.84%
143.30M
1,696.26%
13.78M
90.39%
198.80M
1,343.22%
average receivables
2.22M
-
10.60M
377.35%
20.02M
88.91%
81.22M
305.61%
21.80M
73.16%
176.62M
710.21%
21.83M
87.64%
225.88M
934.59%
book value per share
-36.30
-
3.59
109.88%
11.64
224.52%
7.13
38.70%
5.53
22.53%
1.34
75.81%
-0.92
168.72%
24.45
2,762.20%
-2.66
110.88%
29.87
1,222.15%
-5.34
117.86%
33.97
736.66%
capex per share
-0.00
-
-0.05
18,393.33%
-0.03
35.87%
-0.07
119.54%
-0.25
270.13%
-0.00
98.38%
-2.96
-
-4.25
-
-0.00
99.99%
-5.35
902,670.47%
capex to depreciation
-0.07
-
-11.13
14,925.32%
-6.99
37.16%
-5.01
28.37%
-5.67
13.07%
-0.06
98.86%
-1.41
-
-2.03
-
-0.02
98.81%
-2.00
8,186.54%
capex to operating cash flow
0.00
-
0.02
39,800.27%
0.01
20.27%
0.02
48.60%
0.05
154.64%
0.00
98.31%
-0.66
-
-0.63
-
0.00
100.20%
-0.63
50,706.33%
capex to revenue
-0.50
-
-0.00
99.63%
-0.05
-
-0.04
-
-0.00
99.72%
-0.04
35,271.70%
cash per share
1.61
-
5.95
269.30%
11.94
100.74%
7.72
35.35%
5.78
25.10%
5.21
9.83%
3.50
32.94%
1.49
57.44%
2.47
65.97%
0.99
59.74%
2.36
137.25%
1.56
33.87%
days of inventory on hand
1.20K
-
269.01
77.52%
120.79
55.10%
38.17
68.40%
194.67
409.95%
40.60
79.14%
216.77
433.93%
38.38
82.30%
days payables outstanding
1.07K
-
183.06
82.94%
136.83
25.25%
25.89
81.08%
210.61
713.35%
28.49
86.47%
335.93
1,079.31%
26.51
92.11%
days sales outstanding
73.31
-
61.64
15.92%
49.05
20.43%
29.66
39.53%
31.06
4.73%
28.33
8.80%
37.07
30.85%
24.88
32.87%
debt to assets
22.74
-
0.41
98.18%
0.04
89.41%
0.10
121.61%
0.48
389.01%
0.79
65.79%
1.19
51.25%
0.19
84.36%
1.65
782.14%
0.14
91.48%
2.39
1,604.35%
0.20
91.48%
debt to equity
-1.05
-
0.71
167.72%
0.05
93.52%
0.11
134.71%
0.91
741.99%
3.73
311.38%
-6.18
265.65%
0.34
105.48%
-2.55
851.95%
0.25
109.83%
-1.72
785.86%
0.39
122.67%
dividend yield
0.04
-
0.02
-
0.02
-
earnings yield
-0.99
-
-0.09
90.85%
-0.04
54.13%
-0.11
168.20%
-0.18
63.68%
-0.30
61.99%
-0.14
51.57%
-0.01
94.71%
-0.13
1,634.45%
0.12
194.76%
-0.21
271.94%
0.18
184.83%
enterprise value
61.89M
-
761.32M
1,130.14%
2.28B
199.47%
1.38B
39.50%
1.57B
14.10%
1.05B
33.57%
1.14B
9.47%
757.78M
33.80%
740.82M
2.24%
1.51B
103.23%
555.37M
63.11%
1.26B
126.15%
enterprise value over ebitda
-1.06
-
-12.70
1,095.01%
-22.92
80.46%
-7.57
66.98%
-6.45
14.78%
-5.33
17.31%
-10.77
101.83%
35.32
428.13%
-9.15
125.90%
7.03
176.79%
-10.94
255.72%
5.54
150.60%
ev to operating cash flow
-1.37
-
-15.75
1,045.46%
-26.18
66.22%
-9.87
62.31%
-7.61
22.82%
-5.11
32.93%
-13.89
171.95%
6.08
143.79%
-10.02
264.72%
7.92
179.07%
-24.76
412.52%
5.28
121.35%
ev to sales
71.18
-
10.54
85.20%
6.60
37.32%
0.44
93.30%
3.10
601.47%
0.55
82.42%
2.41
342.48%
0.36
85.08%
free cash flow per share
-5.89
-
-2.78
52.83%
-2.23
19.84%
-3.31
48.74%
-4.97
49.98%
-4.52
9.11%
-1.79
60.37%
1.54
185.96%
-1.59
203.41%
2.54
259.86%
-0.48
118.67%
3.12
756.34%
free cash flow yield
-0.74
-
-0.07
90.29%
-0.04
49.32%
-0.09
140.69%
-0.16
79.53%
-0.27
75.11%
-0.09
67.58%
0.08
187.79%
-0.09
214.30%
0.05
160.35%
-0.07
227.63%
0.09
237.47%
graham net net
-36.36
-
3.41
109.37%
11.41
234.66%
6.95
39.06%
0.89
87.13%
0.57
36.38%
-1.75
407.04%
-11.76
573.02%
-3.89
66.92%
-12.08
210.54%
-6.33
47.63%
-17.39
174.99%
graham number
80.56
-
16.88
79.05%
25.89
53.44%
26.10
0.79%
26.86
2.92%
12.12
54.90%
7.73
36.21%
9.08
17.48%
11.86
30.69%
62.97
430.74%
13.35
78.80%
67.78
407.80%
income quality
0.74
-
0.77
4.32%
0.86
10.88%
0.76
10.86%
0.81
6.30%
0.92
13.78%
0.62
33.00%
-56.63
9,239.29%
0.68
101.20%
1.12
65.14%
0.32
71.41%
1.38
332.26%
intangibles to total assets
0
-
0
0
0
0.02
Infinity%
0.03
45.18%
0.03
16.77%
0.19
548.82%
0.03
84.51%
0.17
470.33%
0
100%
0.20
Infinity%
interest coverage
-27.61
-
-24.07
12.80%
-52.56
118.32%
-30.00
-
-9.09
69.71%
-4.61
49.32%
0.79
117.16%
-3.10
492.60%
40.44
1,402.83%
-2.98
107.36%
26.46
989.24%
interest debt per share
2.02
-
1.52
24.94%
0.05
96.87%
3.98
-
4.46
12.07%
4.78
7.17%
8.60
80.04%
0.63
92.73%
7.68
1,128.08%
7.57
1.41%
13.55
78.96%
inventory turnover
0.31
-
1.36
344.74%
3.02
122.71%
9.56
216.42%
1.87
80.39%
8.99
379.49%
1.68
81.27%
9.51
464.85%
invested capital
-0.05
-
0.38
919.59%
0.69
-
2.97
332.37%
-4.63
256.00%
0.34
107.33%
-0.02
105.94%
0.25
1,345.09%
-1.35
636.99%
0.39
128.95%
market cap
61.19M
-
688.69M
1,025.55%
2.44B
254.24%
1.64B
32.86%
1.39B
15.03%
747.92M
46.26%
927.89M
24.06%
546.25M
41.13%
829.76M
51.90%
1.32B
59.54%
327.23M
75.28%
927.90M
183.56%
net current asset value
-277.42M
-
62.38M
122.49%
459.13M
636.02%
301.70M
34.29%
49.88M
83.47%
48.70M
2.37%
-58.37M
219.86%
-186.86M
220.11%
-134.69M
27.92%
-111.47M
17.24%
-260.77M
133.93%
-196.74M
24.55%
net debt to ebitda
-0.01
-
-1.21
9,951.18%
1.61
232.47%
1.42
11.61%
-0.75
152.61%
-1.52
103.37%
-2.04
34.25%
9.86
583.77%
1.10
88.86%
0.85
22.81%
-4.49
629.98%
1.45
132.18%
net income per share
-7.94
-
-3.53
55.57%
-2.56
27.45%
-4.24
65.74%
-5.80
36.74%
-4.88
15.92%
-2.89
40.79%
-0.15
94.82%
-2.35
1,469.27%
5.90
351.03%
-1.48
125.15%
6.01
505.02%
operating cash flow per share
-5.89
-
-2.73
53.65%
-2.20
19.56%
-3.25
47.74%
-4.72
45.35%
-4.51
4.34%
-1.79
60.33%
4.50
351.46%
-1.59
135.35%
6.79
526.74%
-0.47
106.98%
8.46
1,883.91%
payables turnover
0.34
-
1.99
486.03%
2.67
33.79%
14.10
428.44%
1.73
87.71%
12.81
639.34%
1.09
91.52%
13.77
1,167.41%
receivables turnover
4.98
-
5.92
18.94%
7.44
25.67%
12.31
65.36%
11.75
4.52%
12.88
9.65%
9.85
23.58%
14.67
48.96%
research and ddevelopement to revenue
3.76
-
1.01
73.20%
0.67
33.09%
0.09
86.15%
0.67
617.53%
0.05
92.71%
0.59
1,099.51%
return on tangible assets
-4.76
-
-0.58
87.89%
-0.21
63.48%
-0.54
155.29%
-0.56
4.36%
-0.79
41.21%
-0.63
20.97%
-0.00
99.33%
-0.59
13,941.79%
0.13
122.71%
-0.39
389.60%
0.12
129.95%
revenue per share
0.50
-
2.19
333.45%
3.77
72.10%
61.88
1,543.29%
5.14
91.70%
98.58
1,819.21%
4.86
95.07%
124.12
2,452.24%
roe
0.22
-
-0.98
549.82%
-0.22
77.64%
-0.60
170.39%
-1.05
76.51%
-3.65
247.53%
3.15
186.17%
-0.01
100.19%
0.88
14,517.99%
0.20
77.63%
0.28
40.79%
0.18
36.38%
roic
5.55
-
-1.21
121.82%
-0.63
47.80%
1.01
260.05%
-1.13
211.65%
-1.24
10.19%
-1.53
23.04%
0.01
100.47%
67.84
939,971.87%
0.15
99.78%
0.92
520.04%
0.12
86.52%
sales general and administrative to revenue
8.44
-
1.86
78.02%
0.88
52.52%
0.08
90.45%
0.60
617.53%
shareholders equity per share
-36.30
-
3.59
109.88%
11.64
224.52%
7.13
38.70%
5.53
22.53%
1.34
75.81%
-0.92
168.72%
24.45
2,762.20%
-2.66
110.88%
29.87
1,222.15%
-5.34
117.86%
33.97
736.66%
stock based compensation to revenue
1.58
-
0.29
81.73%
0.14
52.89%
0.01
95.70%
0.10
1,666.32%
0.01
93.62%
0.10
1,400.62%
0.01
94.64%
tangible asset value
-277.30M
-
63.46M
122.89%
461.29M
626.85%
307.18M
33.41%
233.86M
23.87%
53.25M
77.23%
-48.86M
191.76%
440.73M
1,001.99%
-129.44M
129.37%
582.42M
549.94%
-252.30M
143.32%
589.80M
333.76%
tangible book value per share
-36.30
-
3.59
109.88%
11.64
224.52%
7.13
38.70%
5.34
25.15%
1.17
78.01%
-1.06
190.42%
15.76
1,584.64%
-2.79
117.68%
20.67
841.95%
-5.34
125.81%
20.07
476.16%
working capital
-22.68M
-
86.77M
482.69%
459.13M
429.11%
302.08M
34.20%
216.08M
28.47%
228.60M
5.80%
141.80M
37.97%
138.97M
2.00%
107.38M
22.73%
190.26M
77.20%
78.29M
58.85%
289.81M
270.17%

All numbers in (except ratios and percentages)